ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Anti-Aging Drugs Market Forecast Report to 2040, with Profiles of AgelessRx, Betterhumans, BioAge Labs, bioXcellerator, Cambrian Biopharma, Rejuvenate Bio, UT Health San Antonio, and More - ResearchAndMarkets.com

The "Anti-Aging Drugs Market Industry Trends and Global Forecasts to 2040: Distribution by Type of Molecule, Type of Aging, and Geographical Regions and Sales Forecast of Drugs" report has been added to ResearchAndMarkets.com's offering.

The anti-aging drugs market is estimated to grow from USD 79 million in the 2025, to USD 2.80 billion by 2040, representing a higher CAGR of 27% during the forecast period.

Anti-Aging Therapeutics Market: Growth and Trends

Researchers and innovators worldwide are focusing their efforts on the development of therapeutics that can extend life expectancy of an individual by targeting the pathophysiology of aging. Numerous start-ups and academic / research institutes globally are exploring a variety of anti-aging therapies at various stages of development. It is worth mentioning that anti-aging drug providing companies are using various methods, such as advancements in rigorous clinical trial services to expedite market approval procedure and incorporation of artificial intelligence to develop better anti-aging drugs. Additionally, technological advancements like organ-on-chip (promising alternative to conventional testing procedures) in the anti-aging domain has resulted in the development of targeted and effective longevity drugs. With the growing geriatric population, the ongoing R&D initiatives and the increasing funding investments, the anti-aging therapeutics market is expected to experience significant growth in the foreseen future.

With the growing geriatric population, the ongoing R&D initiatives and the increasing funding investments, the anti-aging therapeutics market is expected to experience significant growth in the foreseen future.

Anti-Aging Therapeutics Market: Key Insights

The report delves into the current state of the anti-aging therapeutics market and identifies potential growth opportunities within industry.

Some key findings from the report include:

Presently, more than 65 anti-aging therapeutics are being developed worldwide; majority of the developers are small firms based in North America.

  • These therapeutics, ranging from a variety of biologics and small molecules, are currently being investigated across different phases of development.
  • More than 55% of partnership agreements were inked in the past two years.
  • ~USD 4 billion has been invested by both private and public investors, since 2018
  • Over 660 patents related to anti-aging therapeutics have recently been filed / granted, indicating the growing intellectual capital in this domain.
  • 230+ articles related to anti-aging therapeutics have been published over the last four years.
  • The market is expected to grow at an annualized rate of over 15%; the overall opportunity is anticipated to be well distributed across different types of molecules, types of aging and key geographical regions.
  • Europe and Asia Pacific are anticipated to capture more than 75% of the market share, by 2040.

Anti-Aging Therapeutics Market: Research Coverage

  • Market Sizing and Opportunity Analysis: The report features a thorough analysis of the global anti-aging therapeutics market, in terms of the key market segments, namely type of molecule, type of aging, geographical regions and sales forecast of drugs.
  • Market Landscape: An in-depth assessment of the companies involved in anti-aging therapeutics market, based on several relevant parameters, such as year of establishment, company size, location of headquarters, phase of development, type of aging, type of molecule, mechanism of action, type of developer.
  • Company Competitiveness Analysis: A comprehensive competitive analysis of anti-aging therapeutics market, examining factors, such as developer strength and portfolio strength and portfolio diversity.
  • Company Profiles: Detailed profiles of key developers engaged in the anti-aging therapeutics market, focused on overview of the company, financial information (if available), drug portfolio, and recent developments and an informed future outlook.
  • Patent Analysis: An insightful analysis of the various patents filed / granted in anti-aging therapeutics market, based on various parameters, such as type of patent, patent publication year, geography, CPC Symbols, type of applicant, emerging focus area, patent age, patent benchmarking, patent characteristics, and patent valuation.
  • Publication Analysis: An insightful analysis of the overall publications reported in this domain, based on various parameters, such as year of publication, type of publication and geography.

Key Questions Answered in this Report

  • How many companies are currently engaged in this market?
  • Which are the leading companies in this market?
  • What factors are likely to influence the evolution of this market?
  • What is the current and future market size?
  • What is the CAGR of this market?
  • How is the current and future market opportunity likely to be distributed across key market segments?

Key Players in the Anti-aging Therapeutics Market Profiled in the Report Include

  • AgelessRx
  • ANOVA Institute of Regenerative Medicine
  • Betterhumans
  • BioAge Labs
  • bioXcellerator
  • Cambrian Biopharma
  • Gero.ai, Mayo Clinic
  • Rejuvenate Bio
  • UT Health San Antonio

Reasons to Buy this Report

  • The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
  • Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
  • The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

Additional Benefits

  • Complimentary Excel Data Packs for all Analytical Modules in the Report
  • 15% Free Content Customization
  • Detailed Report Walkthrough Session with Research Team

Report Segmentation

Type of Molecule

  • Biologics
  • Small Molecules

Type of Aging

  • Cellular Aging
  • Immune Aging
  • Metabolic Aging
  • Others

Geographical Regions

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

For more information about this report visit https://www.researchandmarkets.com/r/l1x5iz

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.41
+1.37 (0.56%)
AAPL  268.47
-1.30 (-0.48%)
AMD  233.54
-4.16 (-1.75%)
BAC  53.20
-0.09 (-0.17%)
GOOG  279.70
-5.64 (-1.98%)
META  621.71
+2.77 (0.45%)
MSFT  496.82
-0.28 (-0.06%)
NVDA  188.15
+0.07 (0.04%)
ORCL  239.26
-4.54 (-1.86%)
TSLA  429.52
-16.39 (-3.68%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.